Curaleaf Holdings (CURLF) Non Operating Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Non Operating Income of -$29.4 million for Q1 2026, down 14.03% year-over-year from -$34.2 million in Q1 2025, and down 8.61% quarter-over-quarter from -$27.1 million in Q4 2025.
Curaleaf Holdings (CURLF) Non Operating Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Non Operating Income history runs 8 years deep, the most recent figure standing at -$29.4 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 14.03% year-over-year to -$29.4 million; the TTM figure through Mar 2026 stood at -$107.3 million (up 23.21% YoY), while the FY2025 annual figure was -$103.7 million, up 24.94% from the prior year.
- Non Operating Income for Q1 2026 stood at -$29.4 million, down from -$27.1 million in the prior quarter.
- The five-year high for Non Operating Income was -$3.2 million in Q2 2022, with the low at -$74.6 billion in Q4 2023.
- The 5-year median for Non Operating Income is -$25.2 million (2024), against an average of -$4.7 billion.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income sank 44383.47% in 2023, then surged 99.91% in 2024.
- Curaleaf Holdings' Non Operating Income stood at -$167.7 million in 2022, then tumbled by 44383.47% to -$74.6 billion in 2023, then soared by 99.91% to -$68.2 million in 2024, then soared by 60.35% to -$27.1 million in 2025, then fell by 8.61% to -$29.4 million in 2026.
- Business Quant data shows CURLF's Non Operating Income at -$29.4 million in Q1 2026, -$27.1 million in Q4 2025, and -$28.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | -30.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.53 Mn |
| Mar 31, 2026 | -29.38 Mn |
| Dec 31, 2025 | -27.05 Mn |
| Sep 30, 2025 | -28.34 Mn |
| Jun 30, 2025 | -22.51 Mn |
| Mar 31, 2025 | -25.77 Mn |
| Dec 31, 2024 | -68.23 Mn |
| Sep 30, 2024 | -21.01 Mn |
| Jun 30, 2024 | -24.71 Mn |
| Mar 31, 2024 | -24.19 Mn |
| Dec 31, 2023 | -74.59 Bn |
| Sep 30, 2023 | -51.17 Mn |
| Jun 30, 2023 | -20.36 Mn |
| Dec 31, 2022 | -167.69 Mn |
| Sep 30, 2022 | -23.97 Mn |
| Jun 30, 2022 | -3.20 Mn |
| Mar 31, 2022 | -22.35 Mn |
| Dec 31, 2021 | -50.86 Mn |
| Sep 30, 2021 | -38.96 Mn |
| Jun 30, 2021 | -19.03 Mn |